Clinical trial
Assessment of MDD Management Strategies in Andalusia: A Sub-analysis of the PismaEP Study
NCT01510886 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of MDD Management Strategies in Andalusia: A Sub-analysis of the PismaEP Study
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2012
- Completion date
- September 30, 2013
- Enrollment
- 5,309 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
mdd management strategies